250 related articles for article (PubMed ID: 12823601)
1. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.
Rokuhara A; Tanaka E; Matsumoto A; Kimura T; Yamaura T; Orii K; Sun X; Yagi S; Maki N; Kiyosawa K
J Viral Hepat; 2003 Jul; 10(4):324-30. PubMed ID: 12823601
[TBL] [Abstract][Full Text] [Related]
2. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load.
Kimura T; Rokuhara A; Sakamoto Y; Yagi S; Tanaka E; Kiyosawa K; Maki N
J Clin Microbiol; 2002 Feb; 40(2):439-45. PubMed ID: 11825954
[TBL] [Abstract][Full Text] [Related]
3. [Fundamental and clinical evaluation of hepatitis B virus core-related antigen assay by LUMIPULSE f].
Tanaka Y; Takagi K; Hiramatsu K; Naganuma H; Iida T; Takasaka Y; Mizokami M
Rinsho Byori; 2006 Jul; 54(7):692-8. PubMed ID: 16913659
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
Tanaka E; Matsumoto A; Yoshizawa K; Maki N
Intervirology; 2008; 51 Suppl 1():3-6. PubMed ID: 18544941
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.
Wong DK; Tanaka Y; Lai CL; Mizokami M; Fung J; Yuen MF
J Clin Microbiol; 2007 Dec; 45(12):3942-7. PubMed ID: 17942661
[TBL] [Abstract][Full Text] [Related]
6. The significance of enzyme immunoassay for the assessment of hepatitis B virus core-related antigen following liver transplantation.
Fujimoto M; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Nagaoka S; Yatsuhashi H; Kanematsu T; Eguchi K
Intern Med; 2009; 48(18):1577-83. PubMed ID: 19755758
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection.
Rokuhara A; Sun X; Tanaka E; Kimura T; Matsumoto A; Yao D; Yin L; Wang N; Maki N; Kiyosawa K
J Gastroenterol Hepatol; 2005 Nov; 20(11):1726-30. PubMed ID: 16246193
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Hepatitis B Core-Related Antigen (HBcrAg) During the Natural History of Hepatitis B Virus Infection.
Gou Y; Zhao Y; Rao C; Feng S; Wang T; Li D; Tao C
Clin Lab; 2017 Jul; 63(7):1063-1070. PubMed ID: 28792701
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Hepatitis B Precore/Core-Related Antigens.
Hong X; Luckenbaugh L; Mendenhall M; Walsh R; Cabuang L; Soppe S; Revill PA; Burdette D; Feierbach B; Delaney W; Hu J
J Virol; 2021 Jan; 95(3):. PubMed ID: 33148795
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of hepatitis B core-related antigen in chronic hepatitis B and hepatocellular carcinoma patients.
Chen S; Jia J; Gao Y; Li H; Fang M; Feng H; Guan W; Ji J; Gao Z; Gao C
Clin Chim Acta; 2018 Nov; 486():237-244. PubMed ID: 30025756
[TBL] [Abstract][Full Text] [Related]
11. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA.
Kimura T; Rokuhara A; Matsumoto A; Yagi S; Tanaka E; Kiyosawa K; Maki N
J Clin Microbiol; 2003 May; 41(5):1901-6. PubMed ID: 12734224
[TBL] [Abstract][Full Text] [Related]
12. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.
Maasoumy B; Wiegand SB; Jaroszewicz J; Bremer B; Lehmann P; Deterding K; Taranta A; Manns MP; Wedemeyer H; Glebe D; Cornberg M
Clin Microbiol Infect; 2015 Jun; 21(6):606.e1-10. PubMed ID: 25700889
[TBL] [Abstract][Full Text] [Related]
15. Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation.
Matsuzaki T; Tatsuki I; Otani M; Akiyama M; Ozawa E; Miuma S; Miyaaki H; Taura N; Hayashi T; Okudaira S; Takatsuki M; Isomoto H; Takeshima F; Eguchi S; Nakao K
J Gastroenterol Hepatol; 2013 Jul; 28(7):1217-22. PubMed ID: 23432697
[TBL] [Abstract][Full Text] [Related]
16. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B.
Chang XJ; Sun C; Chen Y; Li XD; Yu ZJ; Dong Z; Bai WL; Wang XD; Li ZQ; Chen D; Du WJ; Liao H; Jiang QY; Sun LJ; Li YY; Zhang CH; Xu DP; Chen YP; Li Q; Yang YP
World J Gastroenterol; 2019 Aug; 25(32):4764-4778. PubMed ID: 31528100
[TBL] [Abstract][Full Text] [Related]
17. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.
Wong DK; Seto WK; Cheung KS; Chong CK; Huang FY; Fung J; Lai CL; Yuen MF
Liver Int; 2017 Jul; 37(7):995-1001. PubMed ID: 27992681
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy.
Inoue T; Watanabe T; Tanaka Y
Clin Mol Hepatol; 2023 Oct; 29(4):851-868. PubMed ID: 36891607
[TBL] [Abstract][Full Text] [Related]
20. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
Sucupira MV; Mello FC; Santos EA; Niel C; Rolla VC; Arabe J; Gomes SA
Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):655-60. PubMed ID: 17072479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
